Abstract:Pluripotency is established through genome-wide reprogramming during mammalian pre-implantation development, resulting in the formation of the naive epiblast. Reprogramming involves both the resetting of epigenetic marks and the activation of pluripotent-cell-specific genes such as Nanog and Oct4 (also known as Pou5f1). The tight regulation of these genes is crucial for reprogramming, but the mechanisms that regulate their expression in vivo have not been uncovered. Here we show that Nanog--but not Oct4--is monoallelically expressed in early pre-implantation embryos. Nanog then undergoes a progressive switch to biallelic expression during the transition towards ground-state pluripotency in the naive epiblast of the late blastocyst. Embryonic stem (ES) cells grown in leukaemia inhibitory factor (LIF) and serum express Nanog mainly monoallelically and show asynchronous replication of the Nanog locus, a feature of monoallelically expressed genes, but ES cells activate both alleles when cultured under 2i conditions, which mimic the pluripotent ground state in vitro. Live-cell imaging with reporter ES cells confirmed the allelic expression of Nanog and revealed allelic switching. The allelic expression of Nanog is regulated through the fibroblast growth factor-extracellular signal-regulated kinase signalling pathway, and it is accompanied by chromatin changes at the proximal promoter but occurs independently of DNA methylation. Nanog-heterozygous blastocysts have fewer inner-cell-mass derivatives and delayed primitive endoderm formation, indicating a role for the biallelic expression of Nanog in the timely maturation of the inner cell mass into a fully reprogrammed pluripotent epiblast. We suggest that the tight regulation of Nanog dose at the chromosome level is necessary for the acquisition of ground-state pluripotency during development. Our data highlight an unexpected role for allelic expression in controlling the dose of pluripotency factors in vivo, adding an extra level to the regulation of reprogramming.

Locus-Specific Isolation of the Nanog Chromatin Identifies Regulators Relevant to Pluripotency of Mouse Embryonic Stem Cells and Reprogramming of Somatic Cells

The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells

Network plasticity of pluripotency transcription factors in embryonic stem cells

A Protein Interaction Network for Pluripotency of Embryonic Stem Cells

Nanog Rna-Binding Proteins Ybx1 and Ilf3 Affect Pluripotency of Embryonic Stem Cells

Kru euro ppel-like factor 5 rewires NANOG regulatory network to activate human naive pluripotency specific LTR7Ys and promote naive pluripotency

Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells

Nanog and transcriptional networks in embryonic stem cell pluripotency

Genome-wide gain-of-function screen identifies novel regulators of pluripotency.

The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells

A Genome-Wide CRISPR Screen Identifies Factors Regulating Pluripotency Exit in Mouse Embryonic Stem Cells

Control of ground-state pluripotency by allelic regulation of Nanog

Systematic Identification of Cis-Regulatory Sequences Active in Mouse and Human Embryonic Stem Cells

NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

Nanog and Oct4 Associate with Unique Transcriptional Repression Complexes in Embryonic Stem Cells.

An Extended Transcriptional Network for Pluripotency of Embryonic Stem Cells.

A Combined In Silico Analysis and In Vitro Experimental Approach

Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells

Transcriptional Regulation of Nanog by OCT4 and SOX2

Pluripotential competence of cells associated with Nanog activity